leadership
Robert-M-Freedman

Robert M. Freedman

Chairman and CEO
  • Previously: CEO—Bullet Cougar Golf. CFO of NYSE-listed Huntway Refining
  • Drexel Burnham Lambert; BancBoston Ventures
  • BS: MIT; MPP: Harvard Kennedy School of Government;
  • MBA (with honors): Harvard Business School.
Cheul Cho

Cheul Cho

Chief Scientific Officer
  • Lead developer of Hurel “microliver” cell cultures
  • PhD: Wayne State University; MS: University of Iowa (Biomedical Eng.)
  • Post-doc: Harvard Medical School (Bio-engineering).
Leslie Z. Benet

Leslie Z. Benet

Co-founder SAB Chairperson
  • Professor of Biopharmaceutical Sciences, UCSF;
  • 19,000 citations of his work in pharmacokinetics;
  • 8 honorary doctorates; Institute of Medicine; founder: AAPS;
  • PhD: UCSF.
James S. MacDonald

James S. MacDonald

SAB Advisor, Preclinical Discovery/Development
  • Developer: Vasotec®, Zocor®, Pepcid®, Clarinex®, Nasonex®, hundreds of others.
  • 2000-2008: EVP of Preclinical Development, Schering-Plough; previously, Executive Director of Toxicology, Merck;
  • PhD: U. of Cincinnati; Diplomate, American Board of Toxicology.

.

Martin Yarmush

Martin Yarmush

Chief Scientifc Advisor
  • internationally recognized academic leader in liver tissue engineering.
  • Director: Center for Engineering in Medicine, MGH/Harvard Med School;
  • Professor of Biomedical Engineering: Rutgers University;
  • MD: Yale; PhD’s: Rockefeller (physical chem), MIT (chemE).
Alexander Ploss

Alexander Ploss

SAB Advisor, Virology
  • Assistant Professor of Molecular Biology, Princeton;
  • PhD: Memorial Sloan-Kettering Cancer Institute (Immunology);
  • Post-doc: Rockefeller (Virology/Infectious Diseases).